Literature DB >> 8094225

Anxiogenic-like effects of yohimbine and idazoxan in two behavioral situations in mice.

P Venault1, F Jacquot, E Save, S Sara, G Chapouthier.   

Abstract

In a light-dark choice situation, the alpha-2 adrenoceptor antagonist idazoxan shows anxiogenic-like effects, which cannot be blocked by the alpha-2 adrenoceptor agonist clonidine, or by the benzodiazepine receptor antagonist Ro 15-1788. In a conditioned conflict situation, both idazoxan and the alpha-2-adrenoceptor yohimbine show anxiogenic-like effects; the effect of idazoxan could not be blocked by clonidine or Ro 15-1788. These data suggest that systems other than alpha-2 adrenoceptors or benzodiazepine receptors must be found to explain these anxiogenic-like properties.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8094225     DOI: 10.1016/0024-3205(93)90455-c

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  4 in total

Review 1.  Rate-dependent behavioral effects of stimulation of central motoric alpha(1)-adrenoceptors: hypothesized relation to depolarization blockade.

Authors:  Eric A Stone; David Quartermain
Journal:  Psychopharmacology (Berl)       Date:  2005-01-12       Impact factor: 4.530

2.  A comparison of dehydroepiandrosterone and 7-keto dehydroepiandrosterone with other drugs that modulate ethanol intake in rats responding under a multiple schedule.

Authors:  Russell Joseph Amato; Mary Worrel Hulin; Peter John Winsauer
Journal:  Behav Pharmacol       Date:  2012-06       Impact factor: 2.293

3.  Evaluation of an anxiety-related phenotype in galanin overexpressing transgenic mice.

Authors:  Andrew Holmes; Rebecca J Yang; Jacqueline N Crawley
Journal:  J Mol Neurosci       Date:  2002 Feb-Apr       Impact factor: 3.444

4.  Alpha 2-adrenoceptor antagonists potentiate acetylcholinesterase inhibitor effects on passive avoidance learning in the rat.

Authors:  F Camacho; C P Smith; H M Vargas; J T Winslow
Journal:  Psychopharmacology (Berl)       Date:  1996-04       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.